| 詳細情報 |   |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (1,099件)
- Shuhei Takeyama, Hironari Hanaoka, Akiyoshi Hashimoto, Yusho Ishii, Yuka Shimizu, Toshiharu Takeuchi, Shuhei Shimoyama, Masataka Kuwana, Tomoaki Higuchi, Masaru Yoshimura, et al. A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study. BMC Rheumatology. 2025. 9. 1
- Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Susumu Nishiyama, Ryutaro Matsumura, Nobuya Hayashi, Takahiro Matsumoto, Toshiki Yabe-Wada, et al. Efficacy of anifrolumab on systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 Trial. Modern rheumatology. 2025
- Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Susumu Nishiyama, Ryutaro Matsumura, Yosuke Morishima, Yoshiyuki Yamaguchi, Gabriel Abreu, et al. Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: post hoc analysis of the Japanese subpopulation of the TULIP-2 study. Modern rheumatology. 2025
- Akihiro Takahashi, Hiroshi Nomoto, Hiroki Yokoyama, Kei Yokozeki, Sho Furusawa, Yuki Oe, Reina Kameda, Shinichiro Kawata, Arina Miyoshi, So Nagai, et al. Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study). Diabetes, obesity & metabolism. 2024
- Haruka Moriya, Yuichiro Fujieda, Yuta Inoue, Kenichi Miyamoto, Mamiko Anada, Daiki Tanaka, Akihiko Kudo, Megumi Abe, Azusa Nagai, Ryo Hisada, et al. Muscle vasculitis in patients with polymyalgia rheumatica; three case series. Modern rheumatology case reports. 2024
- 大江 悠希, 野本 博司, 曹 圭龍, 宮 愛香, 亀田 啓, 中沢 大悟, 古川 真, 西尾 太郎, 中村 昭伸, 坂井 清志, et al. チルゼパチドは慢性腎臓病合併2型糖尿病患者の収縮期血圧を低下させる. 糖尿病. 2024. 67. 12. 511-511
- Ikumi Shigesawa, Akinobu Nakamura, Yuki Yamauchi, Shinichiro Kawata, Asuka Miyazaki, Hiroshi Nomoto, Hiraku Kameda, Yasuo Terauchi, Tatsuya Atsumi. Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice. Journal of diabetes investigation. 2024. 15. 12. 1732-1742
- Yohei Kirino, Ayaka Maeda, Tomoyuki Asano, Kiyoshi Migita, Yukiko Hidaka, Hiroaki Ida, Daisuke Kobayashi, Nobuhiro Oda, Ryo Rokutanda, Yuichiro Fujieda, et al. Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry. Rheumatology (Oxford, England). 2024
- Haruhito A. Uchida, Yoshikazu Nakaoka, Takahiko Sugihara, Hajime Yoshifuji, Yasuhiro Maejima, Yoshiko Watanabe, Hiroko Nagafuchi, Takahiro Okazaki, Yoshinori Komagata, Yoshiya Tanaka, et al. Clinical Characteristics and Treatment Outcomes of Patients With Newly Diagnosed Takayasu Arteritis in Japan During the First 2 Years of Treatment - A Nationwide Retrospective Cohort Study -. Circulation Journal. 2024
- 大江 悠希, 野本 博司, 曹 圭龍, 大森 高志, 中村 昂生, 吉川 純平, 宮 愛香, 加藤 亜樹子, 亀田 啓, 中沢 大悟, et al. 薬物療法1 慢性腎臓病合併2型糖尿病患者に対するデュラグルチドからチルゼパチドへの切替えとその有効性:非盲検2群前向き観察研究. 糖尿病合併症. 2024. 38. Suppl.1. 178-178
- 桑原 咲, 亀田 啓, 宮 愛香, 野本 博司, 曹 圭龍, 中村 昭伸, 小梁川 直秀, 山本 浩平, 竹内 淳, 永井 聡, et al. 薬物療法1 2型糖尿病または耐糖能異常合併高血圧患者におけるエサキセレノンの効果 Ca拮抗薬アムロジピンとの比較. 糖尿病合併症. 2024. 38. Suppl.1. 178-178
- 高橋 明広, 野本 博司, 横山 宏樹, 横関 恵, 古澤 翔, 大江 悠希, 亀田 玲奈, 川田 晋一郎, 三次 有奈, 永井 聡, et al. 薬物療法3 2型糖尿病におけるDPP-4阻害薬とメトホルミン併用療法へのイメグリミン追加による血糖マネジメントへの影響 MEGMI study. 糖尿病合併症. 2024. 38. Suppl.1. 184-184
- Jiang Wei, Yuichiro Fujieda, Yusuke Fujita, Yusuke Ogata, Ryo Hisada, Michihito Kono, Olga Amengual, Masaru Kato, Tatsuya Atsumi. Phosphatidylserine-Dependent Anti-prothrombin Antibodies as a Key Predictor for Systemic Lupus Erythematosus in Patients with Primary Antiphospholipid Syndrome: A retrospective longitudinal cohort study. Modern rheumatology. 2024
- Takako Miyamae, Yusuke Manabe, Takahiko Sugihara, Natsuka Umezawa, Hajime Yoshifuji, Naoto Tamura, Yoshiyuki Abe, Shunsuke Furuta, Hiroko Nagafuchi, Jun Ishizaki, et al. Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective study. Modern rheumatology. 2024
- Shuhei Takeyama, Michihito Kono, Kuniyuki Aso, Kazuro Kamada, Maria Tada, Masato Tarumi, Yui Kosumi, Masaru Yoshimura, Keita Ninagawa, Ryo Hisada, et al. Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus. Modern rheumatology. 2024
- Akihiro Takahashi, Hiroshi Nomoto, Kinnosuke Onishi, Satoru Manda, Aika Miya, Hiraku Kameda, Akinobu Nakamura, Tatsuya Atsumi. A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study). Diabetes, obesity & metabolism. 2024. 26. 8. 3471-3474
- Maiko Miyamoto, Akinobu Nakamura, Aika Miya, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Naoya Iwahara, Kiyohiko Hotta, Nobuo Shinohara, Tatsuya Atsumi. Normalization of impaired glucose tolerance after kidney transplantation is associated with improved β-cell function. American journal of physiology. Endocrinology and metabolism. 2024. 327. 2. E194-E202
- Yuki Oe, Hiroshi Nomoto, Kyu Yong Cho, Kei Yokozeki, Tsubasa Ono, Aika Miya, Hiraku Kameda, Akinobu Nakamura, Yoshiaki Arimura, Tatsuya Atsumi. Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study). BMC endocrine disorders. 2024. 24. 1. 124-124
- Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Susumu Nishiyama, Ryutaro Matsumura, Atsushi Kawakami, Nobuya Hayashi, Gabriel Abreu, et al. The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis. Modern rheumatology. 2024. 34. 4. 720-731
- Aika Miya, Akinobu Nakamura, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi. Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes. Diabetology international. 2024. 15. 3. 465-473
前のページに戻る
